China approves expanded use of contract manufacturing
Monday, April 18, 2016
Stuart Rose, founder and CEO of PaizaBio, discusses the opportunities for growth in China and a new approach for rapid entry into the country’s growing sterile injectables market.
We have updated our privacy policy. In the latest update it explains what cookies
are and how we use them on our site. To learn more about cookies and their benefits,
please view our privacy policy. Please be aware that parts of this site will not
function correctly if you disable cookies. By continuing to use this site, you consent
to our use of cookies in accordance with our privacy policy unless you have disabled
them.
